Evaluation of antitumor effects of two vine stalk oligomers of resveratrol on a panel of lymphoid and myeloid cell lines: Comparison with resveratrol

Life Sciences

Volumn 81, Issue 23-24, 2007, Pages 1565-1574

  Barjot, Catherine ^a   Tournaire, Magali ^a   Castagnino, Chantal ^b   Vigor, Claire ^c   Vercauteren, Joseph ^c   Rossi, Jean François ^a,d  

^a INSERM   (France)

^b Polyphenols R and D SARL   (France)

^c UNIV MONTPELLIER   (France)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

B cell malignancies; e open viniferin; Miyabenol C; Multiple myeloma; Resveratrol

Indexed keywords

CASPASE 2; CASPASE 8; FAS ANTIGEN; MIYABENOL C; OLIGOMER; RESVERATROL; UNCLASSIFIED DRUG; VINIFERIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; MEMBRANE POTENTIAL; MULTIPLE MYELOMA; PROTEIN INTERACTION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HUMANS; LEUKEMIA, LYMPHOID; LEUKEMIA, MYELOID; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; PLANTS; STILBENES;

EID: 36148945251     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.08.047     Document Type: Article

References (41)

1. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research 24 5A (2004) 2783-2840
2. Bernhard D., Tinhofer I., Tonko M., Hubl H., Ausserlechner M.J., Greil R., Kofler R., and Csordas A. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death and Differentiation 7 9 (2000) 834-842
3. Billard C., Izard J.C., Roman V., Kern C., Mathiot C., Mentz F., and Kolb J.P. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leukemia and Lymphoma 43 10 (2002) 1991-2002
4. Boissy P., Andersen T.L., Abdallah B.M., Kassem M., Plesner T., and Delaisse J.M. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Research 65 21 (2005) 9943-9952
5. Brons P.P., Pennings A.H., Haanen C., Wessels H.M., and Boezeman J.B. Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry 11 7 (1990) 837-844
6. Bruno B., Giaccone L., Rotta M., Anderson K., and Boccadoro M. Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside. Leukemia 19 10 (2005) 1729-1738
7. Catlett-Falcone R., Landowski T.H., Oshiro M.M., Turkson J., Levitzki A., Savino R., Ciliberto G., Moscinski L., Fernandez-Luna J.L., Nunez G., Dalton W.S., and Jove R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10 1 (1999) 105-115
8. Catley L., Tai Y.T., Chauhan D., and Anderson K.C. Perspectives for combination therapy to overcome drug-resistant multiple myeloma. Drug Resistance Updates 8 4 (2005) 205-218
9. Chauhan D., Pandey P., Hideshima T., Treon S., Raje N., Davies F.E., Shima Y., Tai Y.T., Rosen S., Avraham S., Kharbanda S., and Anderson K.C. SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells. The Journal of Biological Chemistry 275 36 (2000) 27845-27850
10. Clement M.V., Hirpara J.L., Chawdhury S.H., and Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92 3 (1998) 996-1002
11. Delaunay J.C., Castagnino C., Chèze C., and Vercauteren J. Preparative isolation of polyphenolic compounds from Vitis vinifera by centrifugal partition chromatography. Journal of Chromatography A 964 1-2 (2002) 123-128
12. Delmas D., Rebe C., Lacour S., Filomenko R., Athias A., Gambert P., Cherkaoui-Malki M., Jannin B., Dubrez-Daloz L., Latruffe N., and Solary E. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. The Journal of Biological Chemistry 278 42 (2003) 41482-41490
13. Delmas D., Lancon A., Colin D., Jannin B., and Latruffe N. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Current Drug Targets 7 4 (2006) 423-442
14. Dirsch V.M., Kirschke S.O., Estermeier M., Steffan B., and Vollmar A.M. Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria. Oncogene 23 8 (2004) 1586-1593
15. Dorrie J., Gerauer H., Wachter Y., and Zunino S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Research 61 12 (2001) 4731-4739
16. Estrov Z., Shishodia S., Faderl S., Harris D., Van Q., Kantarjian H.M., Talpaz M., and Aggarwal B.B. Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-KappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102 3 (2003) 987-995
17. Ferry-Dumazet H., Garnier O., Mamani-Matsuda M., Vercauteren J., Belloc F., Billiard C., Dupouy M., Thiolat D., Kolb J.P., Marit G., Reiffers J., and Mossalayi M.D. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23 8 (2002) 1327-1333
18. Hideshima T., Chauhan D., Richardson P., and Anderson K.C. Identification and validation of novel therapeutic targets for multiple myeloma. Journal of Clinical Oncology 23 26 (2005) 6345-6350
19. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 5297 (1997) 218-220
20. Jazirehi A.R., and Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Molecular Cancer Therapeutics 3 1 (2004) 71-84
21. Kurihara H., Kawabata J., Ichikawa S., Mishima M., and Mizutani J. Oligostilbenes from Carex kobomugi. Phytochemistry 30 2 (1991) 649-653
22. Lassus P., Opitz-Araya X., and Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297 5585 (2002) 1352-1354
23. Li W.W., Ding L.S., Li B.G., and Chen Y.Z. Oligostilbenes from Vitis heyneana. Phytochemistry 42 4 (1996) 1163-1165
24. Li H., Zhu H., Xu C.J., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 4 (1998) 491-501
25. Lin C.F., Chen C.L., Chang W.T., Jan M.S., Hsu L.J., Wu R.H., Tang M.J., Chang W.C., and Lin Y.S. Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide and etoposide-induced apoptosis. The Journal of Biological Chemistry 279 39 (2004) 40755-40761
26. Luzi C., Brisdelli F., Cinque B., Cifone G., and Bozzi A. Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Biochemical Pharmacology 68 10 (2004) 2019-2030
27. Micheau O., Solary E., Hammann A., and Dimanche-Boitrel M.T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. The Journal of Biological Chemistry 274 12 (1999) 7987-7992
28. Mohan J., Gandhi A.A., Bhavya B.C., Rashmi R., Karunagaran D., Indu R., and Santhoshkumar T.R. Caspase-2 triggers Bax-Bak-dependent and-independent cell death in colon cancer cells treated with resveratrol. The Journal of Biological Chemistry 281 26 (2006) 17599-17611
29. Park J.W., Choi Y.J., Suh S.I., Baek W.K., Suh M.H., Jin I.N., Min D.S., Woo J.H., Chang J.S., Passaniti A., Lee Y.H., and Kwon T.K. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22 10 (2001) 1633-1639
30. Ragione F.D., Cucciolla V., Borriello A., Pietra V.D., Racioppi L., Soldati G., Manna C., Galletti P., and Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochemical and Biophysical Research Communications 250 1 (1998) 53-58
31. Richardson P.G., Mitsiades C.S., Hideshima T., and Anderson K.C. Novel biological therapies for the treatment of multiple myeloma. Best Practice and Research in Clinical Haematology 18 4 (2005) 619-634
32. Roman V., Billard C., Kern C., Ferry-Dumazet H., Izard J.C., Mohammad R., Mossalayi D.M., and Kolb J.P. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. British Journal of Haematology 117 4 (2002) 842-851
33. Shima Y., Nishimoto N., Ogata A., Fujii Y., Yoshizaki K., and Kishimoto T. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 85 3 (1995) 757-764
34. Shimizu T., Nakazato T., Xian M.J., Sagawa M., Ikeda Y., and Kizaki M. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochemical Pharmacology 71 6 (2006) 742-750
35. Signorelli P., and Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. Journal of Nutritional Biochemistry 16 8 (2005) 449-466
36. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., and Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. The Journal of Biological Chemistry 273 34 (1998) 21875-21882
37. Surh Y.J., Hurh Y.J., Kang J.Y., Lee E., Kong G., and Lee S.J. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Letters 140 1-2 (1999) 1-10
38. Tinhofer I., Bernhard D., Senfter M., Anether G., Loeffler M., Kroemer G., Kofler R., Csordas A., and Greil R. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. The FASEB Journal 15 9 (2001) 1613-1615
39. Tsan M.F., White J.E., Maheshwari J.G., Bremner T.A., and Sacco J. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. British Journal of Haematology 109 2 (2000) 405-412
40. Wang Y., Wang B., Cheng J., Yang L., Liu Z.L., Balan K., Pantazis P., Wyche J.H., and Han Z. FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene. Biochemical Pharmacology 69 2 (2005) 249-254
41. Wieder T., Prokop A., Bagci B., Essmann F., Bernicke D., Schulze-Osthoff K., Dorken B., Schmalz H.G., Daniel P.T., and Henze G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 15 11 (2001) 1735-1742